Search research articles
Contact Us
Filters
Showing results (21-30 of 87) with videos related to
Page
of 9
Sort By:
HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues
|
February 6, 1998
What is it exactly that you do? A "snapshot" of an ethicist at work
C M Ehleben, B H Childs, S L Saltzman
Plant, Cell & Environment
|
April 20, 2012
Clinal variation in the non-acclimated and cold-acclimated freezing tolerance of Arabidopsis thaliana accessions
Ellen Zuther, Elisa Schulz, Liam H Childs, et al.
The American Journal of Medicine
|
February 24, 2001
Acute bacterial endocarditis during granulocytopenia in an allogenic marrow transplant recipient
A Safdar, B H Childs, D Keefe, et al.
The American Journal of Cardiology
|
October 1, 1977
Provocative testing for coronary arterial spasm: rationale, risk and clinical illustrations
C Nelson, B Nowak, H Childs, et al.
The Lancet. Oncology
|
July 28, 2022
PI3K inhibitors in haematological malignancies
Matthew J Matasar, Florian Hiemeyer, Barrett H Childs, et al.
Clinical Breast Cancer
|
February 26, 2014
Phase II multicenter study of docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancer
Lee S Schwartzberg, Suprith Badarinath, Mark R Keaton, et al.
Cancer Journal (Sudbury, Mass.)
|
February 11, 2005
High-dose-rate brachytherapy in combination with stenting offers a rapid and statistically significant improvement in quality of life for patients with endobronchial recurrence
Ron Allison, Claudio Sibata, Kalika Sarma, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
August 18, 2004
RIP kinase is involved in arsenic-induced apoptosis in multiple myeloma cells
O Bajenova, B Tang, R Pearse, et al.
Journal of Neuro-Oncology
|
January 5, 2000
High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors
L E Abrey, M K Rosenblum, E Papadopoulos, et al.
Clinical Pharmacology and Therapeutics
|
January 16, 2024
Model-Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen
Peter N Morcos, Jonathan Moss, Josh Veasy, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 87) with videos related to
Sort By:
Page
of 9
HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues
|
February 6, 1998
What is it exactly that you do? A "snapshot" of an ethicist at work
C M Ehleben, B H Childs, S L Saltzman
Plant, Cell & Environment
|
April 20, 2012
Clinal variation in the non-acclimated and cold-acclimated freezing tolerance of Arabidopsis thaliana accessions
Ellen Zuther, Elisa Schulz, Liam H Childs, et al.
The American Journal of Medicine
|
February 24, 2001
Acute bacterial endocarditis during granulocytopenia in an allogenic marrow transplant recipient
A Safdar, B H Childs, D Keefe, et al.
The American Journal of Cardiology
|
October 1, 1977
Provocative testing for coronary arterial spasm: rationale, risk and clinical illustrations
C Nelson, B Nowak, H Childs, et al.
The Lancet. Oncology
|
July 28, 2022
PI3K inhibitors in haematological malignancies
Matthew J Matasar, Florian Hiemeyer, Barrett H Childs, et al.
Clinical Breast Cancer
|
February 26, 2014
Phase II multicenter study of docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancer
Lee S Schwartzberg, Suprith Badarinath, Mark R Keaton, et al.
Cancer Journal (Sudbury, Mass.)
|
February 11, 2005
High-dose-rate brachytherapy in combination with stenting offers a rapid and statistically significant improvement in quality of life for patients with endobronchial recurrence
Ron Allison, Claudio Sibata, Kalika Sarma, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
August 18, 2004
RIP kinase is involved in arsenic-induced apoptosis in multiple myeloma cells
O Bajenova, B Tang, R Pearse, et al.
Journal of Neuro-Oncology
|
January 5, 2000
High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors
L E Abrey, M K Rosenblum, E Papadopoulos, et al.
Clinical Pharmacology and Therapeutics
|
January 16, 2024
Model-Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen
Peter N Morcos, Jonathan Moss, Josh Veasy, et al.
Page
of 9